|
|
|
|
|
|
S&P Biotech SPDR (XBI)
|
|
85.62 -0.09 (-0.11%)
|
10/20/2017 4:00pm
|
|
Open:
|
85.66
|
Pre. Close:
|
85.71
|
|
High:
|
85.94
|
Low:
|
84.72
|
|
Volume:
|
5,151,715
|
Market Cap:
|
N/A
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
86.26 - 87.33
|
87.33 - 88.21
|
|
Low:
|
82.42 - 83.65
|
83.65 - 84.67
|
|
Close:
|
84.23 - 85.82
|
85.82 - 87.12
|
|
|
|
|
|
|
Technical analysis (as of: 2017-10-20 4:43:12 PM)
|
|
Overall:
|
|
|
Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 101.24  One year: 103.93
|
|
Support:
|
Support1: 82.96 Support2: 69.02
|
|
Resistance:
|
Resistance1:
86.68 Resistance2: 88.98
|
|
Pivot:
|
87.25 
|
|
Moving Averages:
|
MA(5): 86.24 MA(20): 86.66
MA(100): 79.93 MA(250): 71.54
|
|
MACD:
|
MACD(12,26):
0.74 Signal(12,26,9): 1.18
|
|
%K %D:
|
%K(14,3): 28.29 %D(3): 41.75
|
|
RSI:
|
RSI(14): 49.54
|
|
52-Week:
|
High: 88.98
Low: 53.15 Change(%): 44.8
|
|
Average Vol(K):
|
3-Month: 298628
10-Days 74076
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.XBI has closed above bottom band by 3.9%. Bollinger Bands are 46.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to XBI's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Fri, 13 Oct 2017 15:11:15 GMT
SPDR S&P Biotech ETF Experiences Big Outflow
Sat, 16 Sep 2017 11:03:45 GMT
SPDR S&P Biotech (ETF) (XBI): The Quick Guide to XBI
Thu, 05 Oct 2017 11:37:30 GMT
Pete Najarian Sees Unusual Options Activity In SPDR S&P Biotech
Fri, 23 Jun 2017 12:11:15 GMT
Is the SPDR S&P Biotech (ETF) (XBI) Done Running?
Wed, 14 Jun 2017 12:11:15 GMT
The SPDR S&P Biotech (ETF) (XBI) Is on Breakout Watch
|
|
|
Financial Analysis
|
|
Growth
|
NA
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
NA
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
